The fascinating link between gut and bladder
Once believed to be sterile, the bladder hosts its own microbiota. Now, scientists are uncovering how the gut microbiota influences urinary health. Could this unlock new treatments?
Growing evidence suggests a possible connection through the so-called gut-bladder axis, with potential implications for new therapeutic strategies. Let’s explore how these systems interact, the underlying biological mechanisms, and the potential implications for future treatments.
The bladder microbiome or urobiome
The bladder microbiome, or urobiome, encompasses all the microorganisms and their genetic material found in urine. Its study is challenging due to the low number of microbes (10² to 10⁴ CFU/ml) present in urine compared to the gut. Despite this, research confirms a diverse range of organisms, including bacteria, fungi, and viruses. Some commonly detected bacteria include Lactobacillus, Corynebacterium, Gardnerella, Streptococcus, and Escherichia coli. The urobiome’s composition varies among individuals based on factors like age, sex, and health status. Nevertheless, it plays a crucial role in urinary health by maintaining the bladder lining, protecting against infections, regulating nerve signalling, and supporting immune function.
The gut-bladder connection: a two-way connection
The gut microbiota is home to trillions of microorganisms that influence not only digestion and nutrient absorption, but also immune regulation and overall systemic health. Growing research continues to reveal that what happens in the gut extends far beyond the digestive system, affecting distant organs, including the bladder. Changes in gut microbiota composition, immune signalling, and microbial metabolites can influence bladder function, while disturbances in the bladder environment may also impact gut health.
Key biological mechanisms
The gut and bladder interact through metabolic, immune, neural, and hormonal pathways, creating a dynamic relationship between these systems. In the following section, we examine these four communication pathways driving the gut-bladder connection.
Metabolic communication
Metabolites produced by the gut microbiota act as important messengers in the gut-bladder axis, influencing bladder health and immune responses. Short-chain fatty acids (SCFAs) for example, produced during the fermentation of dietary fibers, maintain gut barrier integrity, modulate immune cell function, and impact systemic inflammation, potentially affecting the bladder. Tryptophan metabolites like indole have anti-inflammatory properties. They regulate immune responses in both the gut and bladder, and support urothelial integrity, reducing the risk of infections. Additionally, secondary bile acids, such as deoxycholic and lithocholic acid, help regulate microbial balance and inhibit pathogens, reducing the risk of urinary tract infections and supporting bladder health.
Immune system regulation
The gut and bladder are connected through shared immune signalling pathways, meaning imbalances in the gut microbiota (dysbiosis) can directly affect urinary health. One key mechanism is inflammasome activation. Inflammasomes are protein complexes that detect microbial imbalances and, when activated in the gut due to infections, dysbiosis, or stress, release pro-inflammatory cytokines into the bloodstream. These cytokines can reach the bladder, where they weaken the protective epithelial barrier, making it more vulnerable to infections. This increases the risk of chronic urinary tract infections, highlighting how immune signals from the gut influence bladder health.
Neural pathways: the gut-brain-bladder axis
The gut-brain-bladder axis is a communication network linking the gastrointestinal system, central nervous system, and bladder. The vagus nerve plays a key role in this communication, regulating bladder function and sensory integration. Inflammatory processes can disrupt this network, leading to increased bladder sensitivity and chronic pain. Additionally, gut microbiota-derived neurotransmitters (serotonin, GABA) help maintain urinary regulation. When the gut microbiota is disrupted, these signals become imbalanced, contributing to overactive bladder symptoms, increased pain perception, and urinary dysfunction, often linked to anxiety and depression.
Hormones: the role of the oestrobolome
Oestrogen is essential for maintaining urinary health by supporting the epithelial barrier, mucosal lining, and immune defence. The oestrobolome, a network of gut microbes, regulates oestrogen metabolism through enzymes like β-glucuronidase, controlling active oestrogen levels. When microbiome imbalances disrupt oestrogen levels, bladder function declines, leading to symptoms such as urgency, frequency, and pain. Additionally, oestrogen promotes urothelial protective proteins, which help prevent UTIs.
Challenges in managing urinary health
Managing urinary health presents significant challenges, particularly in cases of recurrent urinary tract infections and chronic bladder inflammation (interstitial cystitis). Traditional antibiotic treatments, while widely used, come with notable drawbacks such as antibiotic resistance, dysbiosis, and other unwanted side effects. In conditions like interstitial cystitis, which are not primarily bacterial, these treatments often provide little relief. Moreover, prolonged antibiotic use may lead to complications including gastrointestinal disturbances and Clostridium difficile infections.
The future of urinary health
Emerging research into the gut-bladder connection is paving the way for innovative strategies in urinary health management. Microbiota-based therapies such as probiotics, dietary interventions and fecal microbiota transplants are now being explored as promising alternatives to conventional treatments.
Lactobacillus-based probiotic formulations have garnered significant attention due to their ability to restore and maintain a balanced urinary and vaginal microbiota. Additionally, gut-derived metabolites may help regulate inflammation in the urinary tract, while identifying microbiome biomarkers could enable early detection and prevention of urinary conditions.
Empowering women’s health
We at Winclove position women’s health as a cornerstone of our product development strategy, reflecting our scientific expertise and dedication to driving improved health outcomes. Recognizing the global potential of probiotics, we collaborate with partners to develop innovative solutions that support women’s health. This commitment aims to empower women to flourish and address unmet medical needs. Our product development team has already integrated current insights in this area and remains committed to monitoring ongoing research. We look forward to incorporating new scientific findings into future product updates, enhancing the quality of life for as many women as possible worldwide.
Interesting updates in your mailbox
Subscribe to our newsletter and receive the latest news about Winclove, probiotic-related research & publications, relevant market developments and inspiring articles.
